We are live on ! Find out more
XT

XTX Topco Portfolio holdings

AUM $5.75B
1-Year Est. Return 30.56%
This Fund
S&P 500
This Quarter Est. Return
+12.88%
1 Year Est. Return
+30.56%
3 Year Est. Return
+70.38%
5 Year Est. Return
+43.83%
10 Year Est. Return
AUM
$457M
AUM Growth
-$129M
Cap. Flow
-$169M
Cap. Flow %
-37.03%
Top 10 Hldgs %
4.33%
Holding
2,338
New
828
Increased
281
Reduced
395
Closed
822

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$2.95M
2
VTYX
Ventyx Biosciences
VTYX
+$2.44M
3
WMT icon
Walmart Inc
WMT
+$1.99M
4
UNH icon
UnitedHealth
UNH
+$1.8M
5
TSLA icon
Tesla
TSLA
+$1.71M

Top Sells

Rank Stock Value
1
ELV icon
Elevance Health
ELV
+$3.17M
2
LLY icon
Eli Lilly
LLY
+$2.9M
3
ATVI
Activision Blizzard
ATVI
+$2.88M
4
GWW icon
W.W. Grainger
GWW
+$2.69M
5
V icon
Visa
V
+$2.6M

Sector Composition

Rank Sector Weight
1 Healthcare 15.57%
2 Technology 15.35%
3 Industrials 14.16%
4 Consumer Discretionary 13.85%
5 Financials 12.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALTR
2251
DELISTED
Altair Engineering Inc
ALTR
-3,383
Closed -$212K
EDR
2252
DELISTED
Endeavor Group Holdings, Inc.
EDR
-11,833
Closed -$235K
ACHL
2253
DELISTED
Achilles Therapeutics
ACHL
-21,084
Closed -$19.2K
INFN
2254
DELISTED
Infinera Corporation Common Stock
INFN
-47,613
Closed -$199K
STBX
2255
DELISTED
Starbox Group Holdings Ltd. Class A Ordinary Shares
STBX
-16
Closed -$36.3K
NKLA
2256
DELISTED
Nikola Corporation Common Stock
NKLA
-10,256
Closed -$483K
NARI
2257
DELISTED
Inari Medical, Inc. Common Stock
NARI
-6,290
Closed -$411K
RVNC
2258
DELISTED
Revance Therapeutics, Inc.
RVNC
-19,908
Closed -$228K
VINC
2259
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
-842
Closed -$17.4K
SMAR
2260
DELISTED
Smartsheet Inc.
SMAR
-24,877
Closed -$1.01M
TFFP
2261
DELISTED
TFF Pharmaceuticals, Inc. Common Stock
TFFP
-875
Closed -$7.66K
SRCL
2262
DELISTED
Stericycle Inc
SRCL
-6,069
Closed -$271K
GVP
2263
DELISTED
GSE Systems, Inc.
GVP
-1,627
Closed -$3.29K
PETQ
2264
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
-13,148
Closed -$259K
SHCR
2265
DELISTED
Sharecare, Inc. Class A Common Stock
SHCR
-64,616
Closed -$60.8K
NTBL
2266
DELISTED
Notable Labs, Ltd. Ordinary Shares
NTBL
-335
Closed -$2.86K
SEEL
2267
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
-26
Closed -$18.3K
EVA
2268
DELISTED
Enviva Inc.
EVA
-42,352
Closed -$316K
PRFT
2269
DELISTED
Perficient Inc
PRFT
-10,124
Closed -$586K
PWSC
2270
DELISTED
PowerSchool Holdings, Inc.
PWSC
-14,066
Closed -$319K
BIG
2271
DELISTED
Big Lots, Inc.
BIG
-97,339
Closed -$497K
VLD
2272
DELISTED
Velo3D, Inc.
VLD
-1,188
Closed -$64.9K
MORF
2273
DELISTED
Morphic Holding, Inc. Common Stock
MORF
-25,715
Closed -$589K
PRST
2274
DELISTED
Presto Technologies, Inc. Common Stock
PRST
-23,300
Closed -$33.3K
CERE
2275
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
-13,739
Closed -$300K

Similar funds

XTX Topco's Q4 2023 Portfolio in Review

As of Q4 2023, XTX Topco held 2,338 positions worth $457M, down 22% from $586M the previous quarter. Its ten largest holdings account for 4.3% of the portfolio.

XTX Topco withdrew a net $169M in Q4 2023, closing 822 positions and reducing 395 holdings. Its most notable exit was Activision Blizzard, an estimated $2.88M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 20% a quarter earlier, followed by Technology and Industrials.

Against the trend, XTX Topco opened a new position in Amazon worth $3.2M.

  • XTX Topco's largest Q4 2023 buy was Amazon: 21,037 shares worth $3.2M.
  • XTX Topco added most to Linde in Q4 2023, an estimated $1.12M increase.
  • XTX Topco's biggest Q4 2023 reduction was Elevance Health, cutting an estimated $3.17M.
  • XTX Topco fully exited Activision Blizzard in Q4 2023, selling an estimated $2.88M.
  • XTX Topco's ten largest holdings make up 4.3% of its $457M portfolio in Q4 2023.
  • XTX Topco opened 828 new positions and closed 822 in Q4 2023.
  • XTX Topco's portfolio value fell 22% quarter-over-quarter to $457M.

Based on XTX Topco's 13F filing for Q4 2023, filed 13 Feb 2024.